vs
HELIOS TECHNOLOGIES, INC.（HLIO）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
HELIOS TECHNOLOGIES, INC.的季度营收约是Ultragenyx Pharmaceutical Inc.的1.1倍（$220.3M vs $207.3M），HELIOS TECHNOLOGIES, INC.净利率更高（4.7% vs -62.0%，领先66.7%），Ultragenyx Pharmaceutical Inc.同比增速更快（25.9% vs 13.3%），HELIOS TECHNOLOGIES, INC.自由现金流更多（$18.6M vs $-100.8M），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs 4.6%）
赫利俄斯科技是一家总部位于美国纽约的上市数据分析企业，在运营末期因收购并运营电影订阅服务MoviePass受到广泛关注，该业务最终导致公司破产。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
HLIO vs RARE — 直观对比
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $220.3M | $207.3M |
| 净利润 | $10.3M | $-128.6M |
| 毛利率 | 33.1% | — |
| 营业利润率 | 0.6% | -54.7% |
| 净利率 | 4.7% | -62.0% |
| 营收同比 | 13.3% | 25.9% |
| 净利润同比 | -9.6% | 3.5% |
| 每股收益（稀释后） | $0.31 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | — | $207.3M | ||
| Q3 25 | $220.3M | $159.9M | ||
| Q2 25 | $212.5M | $166.5M | ||
| Q1 25 | $195.5M | $139.3M | ||
| Q4 24 | $179.5M | $164.6M | ||
| Q3 24 | $194.5M | $139.5M | ||
| Q2 24 | $219.9M | $147.0M | ||
| Q1 24 | $212.0M | $108.8M |
| Q4 25 | — | $-128.6M | ||
| Q3 25 | $10.3M | $-180.4M | ||
| Q2 25 | $11.4M | $-115.0M | ||
| Q1 25 | $7.3M | $-151.1M | ||
| Q4 24 | $4.8M | $-133.2M | ||
| Q3 24 | $11.4M | $-133.5M | ||
| Q2 24 | $13.6M | $-131.6M | ||
| Q1 24 | $9.2M | $-170.7M |
| Q4 25 | — | — | ||
| Q3 25 | 33.1% | — | ||
| Q2 25 | 31.8% | — | ||
| Q1 25 | 30.6% | — | ||
| Q4 24 | 30.1% | — | ||
| Q3 24 | 31.1% | — | ||
| Q2 24 | 32.1% | — | ||
| Q1 24 | 31.7% | — |
| Q4 25 | — | -54.7% | ||
| Q3 25 | 0.6% | -106.9% | ||
| Q2 25 | 10.3% | -64.8% | ||
| Q1 25 | 8.7% | -102.6% | ||
| Q4 24 | 7.4% | -74.3% | ||
| Q3 24 | 11.4% | -94.6% | ||
| Q2 24 | 11.8% | -79.1% | ||
| Q1 24 | 9.6% | -151.9% |
| Q4 25 | — | -62.0% | ||
| Q3 25 | 4.7% | -112.8% | ||
| Q2 25 | 5.4% | -69.0% | ||
| Q1 25 | 3.7% | -108.5% | ||
| Q4 24 | 2.7% | -80.9% | ||
| Q3 24 | 5.9% | -95.7% | ||
| Q2 24 | 6.2% | -89.5% | ||
| Q1 24 | 4.3% | -156.8% |
| Q4 25 | — | $-1.28 | ||
| Q3 25 | $0.31 | $-1.81 | ||
| Q2 25 | $0.34 | $-1.17 | ||
| Q1 25 | $0.22 | $-1.57 | ||
| Q4 24 | $0.14 | $-1.34 | ||
| Q3 24 | $0.34 | $-1.40 | ||
| Q2 24 | $0.41 | $-1.52 | ||
| Q1 24 | $0.28 | $-2.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $54.9M | $421.0M |
| 总债务越低越好 | $420.0M | — |
| 股东权益账面价值 | $917.9M | $-80.0M |
| 总资产 | $1.6B | $1.5B |
| 负债/权益比越低杠杆越低 | 0.46× | — |
8季度趋势，按日历期对齐
| Q4 25 | — | $421.0M | ||
| Q3 25 | $54.9M | $202.5M | ||
| Q2 25 | $53.0M | $176.3M | ||
| Q1 25 | $45.9M | $127.1M | ||
| Q4 24 | $44.1M | $174.0M | ||
| Q3 24 | $46.7M | $150.6M | ||
| Q2 24 | $45.0M | $480.7M | ||
| Q1 24 | $37.3M | $112.3M |
| Q4 25 | — | — | ||
| Q3 25 | $420.0M | — | ||
| Q2 25 | $437.2M | — | ||
| Q1 25 | $446.7M | — | ||
| Q4 24 | $450.6M | — | ||
| Q3 24 | $484.7M | — | ||
| Q2 24 | $504.0M | — | ||
| Q1 24 | $521.8M | — |
| Q4 25 | — | $-80.0M | ||
| Q3 25 | $917.9M | $9.2M | ||
| Q2 25 | $911.7M | $151.3M | ||
| Q1 25 | $881.2M | $144.2M | ||
| Q4 24 | $864.4M | $255.0M | ||
| Q3 24 | $885.5M | $346.8M | ||
| Q2 24 | $866.5M | $432.4M | ||
| Q1 24 | $856.6M | $140.3M |
| Q4 25 | — | $1.5B | ||
| Q3 25 | $1.6B | $1.2B | ||
| Q2 25 | $1.6B | $1.3B | ||
| Q1 25 | $1.5B | $1.3B | ||
| Q4 24 | $1.5B | $1.5B | ||
| Q3 24 | $1.6B | $1.5B | ||
| Q2 24 | $1.6B | $1.6B | ||
| Q1 24 | $1.6B | $1.3B |
| Q4 25 | — | — | ||
| Q3 25 | 0.46× | — | ||
| Q2 25 | 0.48× | — | ||
| Q1 25 | 0.51× | — | ||
| Q4 24 | 0.52× | — | ||
| Q3 24 | 0.55× | — | ||
| Q2 24 | 0.58× | — | ||
| Q1 24 | 0.61× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $25.3M | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | $18.6M | $-100.8M |
| 自由现金流率自由现金流/营收 | 8.4% | -48.6% |
| 资本支出强度资本支出/营收 | 3.0% | 0.5% |
| 现金转化率经营现金流/净利润 | 2.46× | — |
| 过去12个月自由现金流最近4个季度 | $91.3M | $-472.0M |
8季度趋势，按日历期对齐
| Q4 25 | — | $-99.8M | ||
| Q3 25 | $25.3M | $-91.4M | ||
| Q2 25 | $37.0M | $-108.3M | ||
| Q1 25 | $19.0M | $-166.5M | ||
| Q4 24 | $35.7M | $-79.3M | ||
| Q3 24 | $34.8M | $-67.0M | ||
| Q2 24 | $33.8M | $-77.0M | ||
| Q1 24 | $17.8M | $-190.7M |
| Q4 25 | — | $-100.8M | ||
| Q3 25 | $18.6M | $-92.7M | ||
| Q2 25 | $31.6M | $-110.7M | ||
| Q1 25 | $12.9M | $-167.8M | ||
| Q4 24 | $28.2M | $-79.5M | ||
| Q3 24 | $28.8M | $-68.6M | ||
| Q2 24 | $25.8M | $-79.0M | ||
| Q1 24 | $12.3M | $-193.9M |
| Q4 25 | — | -48.6% | ||
| Q3 25 | 8.4% | -58.0% | ||
| Q2 25 | 14.9% | -66.5% | ||
| Q1 25 | 6.6% | -120.5% | ||
| Q4 24 | 15.7% | -48.3% | ||
| Q3 24 | 14.8% | -49.2% | ||
| Q2 24 | 11.7% | -53.7% | ||
| Q1 24 | 5.8% | -178.2% |
| Q4 25 | — | 0.5% | ||
| Q3 25 | 3.0% | 0.8% | ||
| Q2 25 | 2.5% | 1.5% | ||
| Q1 25 | 3.1% | 1.0% | ||
| Q4 24 | 4.2% | 0.1% | ||
| Q3 24 | 3.1% | 1.2% | ||
| Q2 24 | 3.6% | 1.4% | ||
| Q1 24 | 2.6% | 3.0% |
| Q4 25 | — | — | ||
| Q3 25 | 2.46× | — | ||
| Q2 25 | 3.25× | — | ||
| Q1 25 | 2.60× | — | ||
| Q4 24 | 7.44× | — | ||
| Q3 24 | 3.05× | — | ||
| Q2 24 | 2.49× | — | ||
| Q1 24 | 1.93× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
HLIO
| Hydraulics | $141.3M | 64% |
| Electronics | $79.0M | 36% |
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
